ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
BetaShares Capital Limited

BetaShares Capital Limited (DRUG)

8.82
-0.02
(-0.23%)
Cerrado 12 Octubre 12:00AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
8.82
Postura de Compra
8.81
Postura de Venta
8.90
Volume Operado de la Acción
22,859
8.80 Rango del Día 8.84
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
8.84
Precio de Apertura
8.81
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
158,230,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
199.55
Beneficio por acción (BPA)
0.04
turnover
7.94M
Beneficio neto
6.99M

Acerca de BetaShares Capital Limited

Sector
Finance Services
Industria
Finance Services
Sede
Sydney, New South Wales, Aus
Fundado
-
BetaShares Capital Limited is listed in the Finance Services sector of the Australian Stock Exchange with ticker DRUG. The last closing price for BetaShares Capital was AUD8.84. Over the last year, BetaShares Capital shares have traded in a share price range of AUD 0.00 to AUD 0.00.

BetaShares Capital currently has 158,230,000 shares in issue. The market capitalisation of BetaShares Capital is AUD1.40 billion. BetaShares Capital has a price to earnings ratio (PE ratio) of 199.55.

DRUG Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CAMPCAMP4 Therapeutics Corporation
 10.75
(2,587.50%)
378.47k
TWGTop Wealth Group Holding Ltd
US$ 7.14
(233.64%)
154.23M
NIVFNewGenIvf Group Ltd
US$ 0.98
(63.42%)
58.51M
ATIFATIF Holdings Ltd
US$ 1.235
(58.33%)
3.85M
VERBVerb Technology Company Inc
US$ 7.91
(51.82%)
15.55M
BYUBAIYU Holdings Inc
US$ 0.299
(-35.28%)
11.11M
TURBTurbo Energy SA
US$ 2.1511
(-29.01%)
3.2M
SMSTDefiance Daily Target 1.5X Short MSTR ETF
US$ 7.898
(-23.62%)
993.33k
VEEAVeea Inc
US$ 3.27
(-23.24%)
284.95k
INHDInno Holdings Inc
US$ 3.74
(-22.41%)
257.75k
JTAIJet AI Inc
US$ 0.1009
(23.50%)
340.09M
CDTConduit Pharmaceuticals Inc
US$ 0.116
(13.28%)
270.97M
NVDANVIDIA Corporation
US$ 134.80
(-0.01%)
170.27M
LUXHLuxUrban Hotels Inc
US$ 0.0532
(5.35%)
165.94M
TWGTop Wealth Group Holding Ltd
US$ 7.14
(233.64%)
154.23M
The Night Stalker The Night Stalker 5 minutos hace
nice
CBDY
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutos hace
Shareholders predictions
GRPS
B402 B402 6 minutos hace
Reduced to fallacies ;) , ho hum.......Its a real problem with social media, left or right......
Lykiri Lykiri 6 minutos hace
'Bonus' version= cell therapy products manufactured in the Sawston facility may be exported globally.
Under this commercial manufacturing license, cell therapy products manufactured in the Sawston facility may be exported globally. Products (e.g., immune cells) may also be imported into the U
NWBO
The Night Stalker The Night Stalker 6 minutos hace
nice
SNTX
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutos hace
Nice run a while back
GRPS
janice shell janice shell 7 minutos hace
LOLOLOLOLISSIMO!! I hope Kamala thanks him for it!
Susie924 Susie924 7 minutos hace
Excellent!
zakattack zakattack 7 minutos hace
someone spent 2 dollars wow something must be going on
GNCP
SwissCheeseAccount SwissCheeseAccount 7 minutos hace
When the final distribution is announced when theirs no more lawsuits, you’ll admit I was right then
LEHNQ
Sammy 967 Sammy 967 7 minutos hace
It has nothing to do with our approval. Completely irrelevant
NWBO
KART4445 KART4445 8 minutos hace
Wonder if this has anything to do with Digital Utilities Ventures now.
Resqnine Resqnine 8 minutos hace
Not that I heard, just bouncing all over
EOSE
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutos hace
Wonder if they can keep the momentum
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutos hace
Great numbers
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutos hace
Maybe billion
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutos hace
Wonder billions market capitalization down the road
DCMDF
janice shell janice shell 10 minutos hace
So sadly true!
Hitman970 Hitman970 10 minutos hace
Fink,
What's the upside potential from here? GPLS$
GPLS
jour_trader jour_trader 10 minutos hace
Always good to start somewhere. I’d remove vigabatrin altogether and cut markets for Vyvanse and OxyContin in half as they shift from brand to generic with competitors. To offset this, I’d also model a more generous market capture. Let’s see that Vyvanse or OxyContin approval first
ELTP
oldstocks oldstocks 10 minutos hace
Crunchbase has Rohan Chanmugam holds 2 board and advisor roles as Board Director at OneMind Technologies and Board Director at Affluence Corporation.

Which we all may have assumed anyway

From what we know he is the acting CEO of OneMind until they get a new replacement
AFFU

Su Consulta Reciente

Delayed Upgrade Clock